Delivery Order SPE2DB22D1017-SPE2DB25FYQFF
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packaging). The contract is valued at $9,434.27 under a firm fixed-price arrangement with an ultimate completion date of August 15, 2025. This delivery order was awarded competitively with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,040.74 for Carvedilol ER 10 mg capsules (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This is a firm fixed price delivery order valued at $4,591.90, with an ultimate completion date of September 3, 2025. The award is a non-set-aside contract and represents a competitive procurement for pharmaceutical supply to support federal medical requirements. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 per unit, with a contract ceiling value of $4,842.98. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,174.62 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count packages) with a contract ceiling value of $4,407.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $5,968.23. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,427.22 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This competitive award, without set-aside designation, is classified as a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYQFFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a contract ceiling value of $2,300.88. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical supplies, and related commodities to support military healthcare programs globally. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with a demonstrated portfolio of diverse pharmaceutical deliveries spanning diabetes medications, neurological treatments, pain management products, antibiotics, and specialty medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/8/25 |